Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ebru Arioglu"'
Autor:
Betül R. Erdogan, Martina B. Michel, Jan Matthes, Tamara R. Castañeda, Urs Christen, Ebru Arioglu-Inan, Martin C. Michel, Andrea Pautz
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Diabetes often leads to lower urinary tract dysfunction. The most frequently assessed parameter of urinary bladder dysfunction in animal models of diabetes is an enlargement of the bladder, which is consistently observed in type 1 and l
Externí odkaz:
https://doaj.org/article/3c4c8537885943eba24676d0fef82fd9
Autor:
Zeynep E. Yesilyurt, Jan Matthes, Edith Hintermann, Tamara R. Castañeda, Ralf Elvert, Jesus H. Beltran-Ornelas, Diana L. Silva-Velasco, Ning Xia, Aimo Kannt, Urs Christen, David Centurión, Huige Li, Andrea Pautz, Ebru Arioglu-Inan, Martin C. Michel
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
The urinary bladder is markedly enlarged in the type 1 diabetes mellitus model of streptozotocin-injected rats, which may contribute to the frequent diabetic uropathy. Much less data exists for models of type 2 diabetes. Diabetic polyuria has been pr
Externí odkaz:
https://doaj.org/article/f59087392e074b2ea5f40362b866547a
Autor:
Zeynep Elif Yesilyurt, Betül Rabia Erdogan, Irem Karaomerlioglu, Ayhanim Elif Muderrisoglu, Martin Christian Michel, Ebru Arioglu-Inan
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Hypertrophy and dysfunction of the urinary bladder are consistently observed in animal models of type 1 and less consistently in those of type 2 diabetes. We have tested the effects of mild hyperglycemia (n = 10 per group) in a randomized, blinded st
Externí odkaz:
https://doaj.org/article/25705396fdc0440e8bbcc8c483c9c073
Publikováno v:
Cells, Vol 9, Iss 12, p 2548 (2020)
Diabetes is a chronic, endocrine disorder that effects millions of people worldwide. Cardiovascular complications are the major cause of diabetes-related morbidity and mortality. Cardiac β1- and β2-adrenoceptor (AR) stimulation mediates positive in
Externí odkaz:
https://doaj.org/article/168c78ecc97248af99f30d5d02bdb6fe
Autor:
Gizem Kaykı-Mutlu, Olga Papazisi, Meindert Palmen, A. H. Jan Danser, Martin C. Michel, Ebru Arioglu-Inan
Publikováno v:
Cells, Vol 9, Iss 11, p 2412 (2020)
As heart failure (HF) is a devastating health problem worldwide, a better understanding and the development of more effective therapeutic approaches are required. HF is characterized by sympathetic system activation which stimulates α- and β-adreno
Externí odkaz:
https://doaj.org/article/2e9a819a32b149aaaf72d5025c8630b6
Publikováno v:
Pharmacology. 107:116-121
Fenoterol is a β2-adrenoceptor (AR)-selective agonist that is commonly used to investigate relaxation responses mediated by β2-AR in smooth muscle preparations. Some data have questioned this because fenoterol had low potency in the rat urinary bla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58aee678712c3d8e0b8454045eb6252f
https://doi.org/10.1159/000519720
https://doi.org/10.1159/000519720
Autor:
Zeynep Elif Yesilyurt, Irem Karaomerlioglu, Betul Rabia Erdogan, Gaye Ozturk, Martin C. Michel, Ebru Arioglu-Inan
Diabetes mellitus leads to cardiovascular complications including impaired cardiac β-adrenoceptor (β-AR) function. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, such as empagliflozin (EMPA) improve outcomes in heart failure patients and animal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac749b97fb2afd3a23880d41f8eeb16
https://doi.org/10.20944/preprints202205.0346.v1
https://doi.org/10.20944/preprints202205.0346.v1
Autor:
Kenan Can Tok, Mehmet Gumustas, Ceyda Tuba Sengel-Turk, Gulin Amasya, Bilge Bayram, Ebru Arioglu-Inan
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 219
The aim of the present study is to develop the polymeric nanoparticulate drug delivery systems of piroxicam and to evaluate the in-vitro characteristics such as entrapment efficiency, surface morphology, in-vitro drug release performance, etc. For th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3f58a39da1aa9380deadabdcd8cd7f
https://pubmed.ncbi.nlm.nih.gov/35908414
https://pubmed.ncbi.nlm.nih.gov/35908414
Autor:
Martin C. Michel, Jesus H. Beltrans‐Ornelas, Diana L. Silva‐Velasco, Tamara R. Castañeda, Ralf Elvert, Aimo Kannt, Ning Xia, Huige Li, Ebru Arioglu‐Inan, David Centurion
Publikováno v:
The FASEB Journal. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::900d8011d8577a58dad3cda1eee14345
https://doi.org/10.1096/fasebj.2022.36.s1.0r858
https://doi.org/10.1096/fasebj.2022.36.s1.0r858
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 395(8)
Dysfunction of the lower urinary tract (LUT) including urinary bladder and urethra (and prostate in men) is one of the most frequent complications of diabetes and can manifest as overactive bladder, underactive bladder, urinary incontinence, and as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ded94107e25792fee6736c315633526
https://pubmed.ncbi.nlm.nih.gov/35545721
https://pubmed.ncbi.nlm.nih.gov/35545721